arthritis advocacy news and regulatory letters

Advocacy News & Regulatory Letters

January 2, 2019

Arthritis Foundation Comments on Medicare IPI Model

The Arthritis Foundation submitted comments to the federal Department of Health and Human Services on a proposal that would change how physician-administered drugs are paid for under the Medicare program. As described in the proposal, we believe the international pricing index (IPI) model’s projected benefits are outweighed by potential negative impacts on patient access. Read the letter here.


Get caught up on news from past years: